Growth Metrics

AtriCure (ATRC) Total Current Liabilities (2016 - 2025)

AtriCure (ATRC) has disclosed Total Current Liabilities for 16 consecutive years, with $81.5 million as the latest value for Q4 2025.

  • On a quarterly basis, Total Current Liabilities rose 11.03% to $81.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was $81.5 million, a 11.03% increase, with the full-year FY2025 number at $81.5 million, up 11.03% from a year prior.
  • Total Current Liabilities was $81.5 million for Q4 2025 at AtriCure, up from $77.8 million in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $82.5 million in Q3 2023 to a low of $47.4 million in Q1 2022.
  • A 5-year average of $65.3 million and a median of $61.9 million in 2023 define the central range for Total Current Liabilities.
  • Peak YoY movement for Total Current Liabilities: soared 77.21% in 2021, then dropped 18.97% in 2022.
  • AtriCure's Total Current Liabilities stood at $56.4 million in 2021, then rose by 3.45% to $58.4 million in 2022, then rose by 27.7% to $74.6 million in 2023, then decreased by 1.54% to $73.4 million in 2024, then grew by 11.03% to $81.5 million in 2025.
  • Per Business Quant, the three most recent readings for ATRC's Total Current Liabilities are $81.5 million (Q4 2025), $77.8 million (Q3 2025), and $68.8 million (Q2 2025).